Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Real-world healthcare resource utilization and medical costs in patients with overweight or obesity and multimorbidity treated with semaglutide in the United States.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: January 12, 2026
Semaglutide 2.4 mg Cardiometabolic Long-Term Effects in Patients With Obesity or Overweight in a Real-World Setting: A Retrospective Cohort Study in the United States (SMILE).
Journal: Diabetes, obesity & metabolism
Published: December 22, 2025
Semaglutide and tirzepatide effects on cardiovascular outcomes in people with overweight or obesity in the real world (STEER).
Journal: Diabetes, obesity & metabolism
Published: November 18, 2025
Showing 1-3 of 3
Last Updated: 09/26/2026